The featured interim data from the study of patients undergoing both the Adductoplasty ® and Lapiplasty ® procedures included interim analysis of 59 of 66 and 35 of 66 patients treated with at least ...

Treace Medical Concepts, Inc. (NASDAQ: TMCI) presented results from three clinical studies at the American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle, Washington, according to a ...

"Achieving this important milestone is a testament to the tireless efforts of our team members and the trust of our surgeon customers and patients, all of whom have made our journey possible," said ...

PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...

The differentiated Lapiplasty procedure is rewarding Treace Medical handsomely with top-line growth. It is capturing share of an under-penetrated instrumental procedures market. Added to that, the ...

Treace Medical Concepts, Inc. ( TMCI ), a medical technology company, announced that it will highlight new product additions and present clinical data at the American Orthopaedic Foot & Ankle Society ...

PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announces presentation of ...

Detailed price information for Treace Medical Concepts Inc (TMCI-Q) from The Globe and Mail including charting and trades.

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus (bunion) surgery, announced that it has received ...